维普期刊资源整合服务平台（V6.5）

31篇 您的检索式：作者名="Gootenberg"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity显示文摘	F. Ann Ran Patrick D. Hsu Chie-Yu Lin Jonathan S. Gootenberg Silvana Konermann Alexandro E. Trevino David A. Scott Azusa Inoue Shogo Matoba Yi Zhang Feng Zhang	2013	Cell2013，，2：	4
2	FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent non- squamous non-small cell lung cancer 显示文摘	Cohen MH Gootenberg J Keegan P	2007	Oncologist2007，12，6：	1
3	Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system显示文摘	Zetsche B Zetsche B Gootenberg J S	2015	Cell2015，163，3：	1
4	FDA drug approval summary: bevacizumab (Avastin) plus earboplatin and paclitaxel as first-line treatment of advanced/metastatic reeurrent nonsquamous non-small cell lung cancer显示文摘	Cohen M H Gootenberg J Keegan P	2007	The Oncologist2007，12，6：	1
5	Continuing reas- sessment of the risks of erythropoiesis-stimulating agents in patients with cancer显示文摘	Juneja V Keegan P Gootenberg JE	2008	Clin Cancer Res2008，14，：	1
6	FDA drug approval summary:pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL)显示文摘	Dinndorf PA Gootenberg J Cohen MH	2007	Oncologist2007，12，：	1
7	FDA drug approval summary:pegaspargase(oncaspar)for the firstline treatment of children with acute lymphoblastic leukemia(ALL)显示文摘	DINNDORF PA GOOTENBERG J COHEN MH	2007	Oncologist2007，12，8：	1
8	FDA drug approval summary: pegaspargase ( Oncaspar ) for the first-line treatment of children with acute lymphoblastie leukemia (ALL) 显示文摘	Dinndorf P A Gootenberg J Cohen M H	2007	Oncologist2007，12，8：	1
9	FDA drug approval summary: bevaeizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer显示文摘	Cohen M H Gootenberg J	2007	Oncologist2007，12，6：	1
10	Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system显示文摘	ZETSCHE B GOOTENBERG J S ABUDAYYEH O O	2015	Cell2015，163，3：	1
11	Companion animals Symposi- um: Humanized animal models of the mierobiome 显示文摘	GOOTENBERG D B TURNBAUGH P J	2011	J Anita Sci2011，，89：	1
12	FDA drug approval summary:Pegasparagase (Oncaspar) for the first-line treatment of children with acurate lymphoblastic leukemia(ALL) 显示文摘	PA Dinndoff J Gootenberg MH Cohen	2007	The on- colcgist2007，12，8：	1
13	FDA drug approval summary: bevacizumab plus FOLFOX4 as second-line treatment of colorectal cancer显示文摘	Cohen M H Gootenberg J Keegan P	2007	Oncologist2007，12，3：	1
14	FDA drug approval summary: Bevacizumab plus FOLFOX4 as second-line treatment of colorectal cancer 显示文摘	Cohen MH Gootenberg J Keegan P	2007	The Oncologist2007，12，3：	1
15	FDA drug approval summary:bevacizumab (Avastin) plus carboplatin and paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer显示文摘	COHEN M H GOOTENBERG J KEEGAN P	2007	Oncologist2007，12，6：	1
16	FDA drug approval summary: bevacizumab(Avastin) plus carboplatin and paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer显示文摘	Cohen M H Gootenberg J Keegan P	2007	Oncologist2007，12，：	1
17	Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity显示文摘	F. Ann Ran Patrick D. Hsu Chie-Yu Lin Jonathan S. Gootenberg Silvana Konermann Alexandro E. Trevino David A. Scott Azusa Inoue Shogo Matoba Yi Zhang Feng Zhang	2013	Cell2013，，2：	1
18	FDA drug approval summary:bevacizumab plus FOLFOX4 as second-line treatment of colorectal cancer显示文摘	Cohen MH Gootenberg J Keegan P	2007	Oncologist2007，12，3：	1
19	FDA drugapproval summary: pegaspargase (oncaspar) for the first-linetreatment of children with acute lymphoblastic leukemia (ALL)显示文摘	Dinndorf PA Gootenberg J Cohen MH	2007	Oncologist2007，12，8：	1
20	FDA drug approv-al summary : pegaspargase ( oncaspar) for the first-line treatmentof children with acute lymphoblastic leukemia ( ALL) 显示文摘	Dinndorf PA Gootenberg J Cohen MH	2007	Oncol-ogist2007，12，8：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示